AU6915874A - 4-hydroxy-3-nitrocarbostyril derivatives and their use in pharmaceutical compositions forthe prophylaxis and treatment of allergic diseases - Google Patents

4-hydroxy-3-nitrocarbostyril derivatives and their use in pharmaceutical compositions forthe prophylaxis and treatment of allergic diseases

Info

Publication number
AU6915874A
AU6915874A AU69158/74A AU6915874A AU6915874A AU 6915874 A AU6915874 A AU 6915874A AU 69158/74 A AU69158/74 A AU 69158/74A AU 6915874 A AU6915874 A AU 6915874A AU 6915874 A AU6915874 A AU 6915874A
Authority
AU
Australia
Prior art keywords
nitrocarbostyril
prophylaxis
hydroxy
derivatives
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU69158/74A
Other versions
AU487257B2 (en
Inventor
Barrie Christian Charles Cantello Harry Smith Derek Richard Buckle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of AU6915874A publication Critical patent/AU6915874A/en
Publication of AU487257B2 publication Critical patent/AU487257B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU69158/74A 1973-05-19 1974-05-20 4-hydroxy-3-nitrocarbostyril derivatives and their use in pharmaceutical compositions forthe prophylaxis and treatment of allergic diseases Expired AU487257B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB2400073A GB1453863A (en) 1973-05-19 1973-05-19 Pharmaceutical compositions comprising nitrocarbostyrils for the treatment of allergic and immunological hypersensitivity
GBGB24000/73 1973-05-19
GB2431773 1973-05-22
GBGB24317/73 1973-05-22

Publications (2)

Publication Number Publication Date
AU6915874A true AU6915874A (en) 1975-11-20
AU487257B2 AU487257B2 (en) 1975-11-20

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631228B2 (en) * 1989-07-24 1992-11-19 Eli Lilly And Company Pyrido (2,3-g) quinolines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631228B2 (en) * 1989-07-24 1992-11-19 Eli Lilly And Company Pyrido (2,3-g) quinolines

Also Published As

Publication number Publication date
IE39269L (en) 1974-11-19
FR2229414B1 (en) 1977-11-10
AR201506A1 (en) 1975-03-21
HU168001B (en) 1976-02-28
GB1453863A (en) 1976-10-27
DK137043B (en) 1978-01-09
DD112126A5 (en) 1975-03-20
SU578869A3 (en) 1977-10-30
AT334373B (en) 1976-01-10
ES426427A1 (en) 1976-09-16
CH601243A5 (en) 1978-06-30
FI153174A (en) 1974-11-20
DE2424076A1 (en) 1974-12-05
NL7406711A (en) 1974-11-21
JPS5030884A (en) 1975-03-27
IL44849A (en) 1978-04-30
IE39269B1 (en) 1978-08-30
ATA409674A (en) 1976-05-15
ZM7974A1 (en) 1974-12-20
SE7406631L (en) 1974-11-20
PH10621A (en) 1977-07-19
CA1030539A (en) 1978-05-02
FR2229414A1 (en) 1974-12-13
IL44849A0 (en) 1974-07-31
DK137043C (en) 1978-06-05
IN139603B (en) 1976-07-10

Similar Documents

Publication Publication Date Title
ZA7468B (en) Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
CA1020869A (en) Tinctorial compositions for human hair and new derivatives thereof
EG11468A (en) Process for the preparation of sulphoxides and pharmaceutical compositions comprising them
AU461863B2 (en) Propanolamine derivatives, their preparation and therapeutic compositions containing thesame
DE2963572D1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
GB1520584A (en) 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
JPS527999A (en) Production of evrnamenine derivatives and pharmaceutical composition
AU471474B2 (en) Method and compositions forthe treatment of human hair
CA921758A (en) Treatment of flour and dough
PH12964A (en) Pyranochromone derivatives and therapeutic composition comprising same for treatment of allergic diseases
AU487257B2 (en) 4-hydroxy-3-nitrocarbostyril derivatives and their use in pharmaceutical compositions forthe prophylaxis and treatment of allergic diseases
AU6915874A (en) 4-hydroxy-3-nitrocarbostyril derivatives and their use in pharmaceutical compositions forthe prophylaxis and treatment of allergic diseases
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
CA1024988A (en) Derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them
AU462834B2 (en) Pharmaceutical composition and method of treatment
JPS5283370A (en) Production of 33nitropyrazole derivatives and pharmaceutical agent with pasteurizing action
AU495056B2 (en) COMPOSITIONS AND TREATMENT OF PROLIFERATIVE SKIN DISEASES WITH b2 AGONISTS
AU6425674A (en) Compositions and treatment of proliferative skin diseases with phosphodiesterase inhibitors
AU2461871A (en) Pharmaceutical compositions useful in the treatment of involuntary movement disorders
AU494716B2 (en) Compositions and treatment of proliferative skin diseases with phosphodiesterase inhibitors
AU494635B2 (en) Hydroxycinnoline derivatives processes for their preparation and their use in pharmaceutical compositions
AU432652B2 (en) Pharmaceutical compositions suitable for cicoatrization processes and forthe treatment of physiological disorders ofthe skin
AU514653B2 (en) Pharmaceutical preparations forthe treatment of disorders in calcium metabolism
AU497298B2 (en) Composition and treatment for skin disease
AU8610175A (en) Hydroxycinnoline derivatives processes for their preparation and their use in pharmaceutical compositions